The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 342:424-425 February 10, 2000 Number 6
NextNext

The Challenge of Thrombophilia in Maternal–Fetal Medicine

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Gerhardt, A.
-PubMed Citation
Twenty years ago we did not have a problem with thrombophilia as a cause of venous thromboembolism in pregnant and postpartum women, or rather, we did not know we had a problem. The only known major thrombophilic disorder was deficiency of antithrombin, and it was found only rarely in such women. Recently, there has been a dramatic increase in the number of identifiable causes of thrombophilia. They include, in addition to antithrombin deficiency, protein C and protein S deficiencies, factor V Leiden, the G20210A mutation of the prothrombin gene, and homozygosity for the thermolabile variant of methylenetetrahydrofolate reductase (C677T MTHFR), . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.